Ellington Management Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,500
| Closed | -$211K | – | 631 |
|
|
2019
Q4 | $211K | Sell |
3,500
-9,300
| -73% | -$561K | 0.04% | 413 |
|
|
2019
Q3 | $767K | Buy |
+12,800
| New | +$767K | 0.14% | 139 |
|
|
2019
Q2 | – | Sell |
-9,100
| Closed | -$739K | – | 656 |
|
|
2019
Q1 | $739K | Buy |
9,100
+3,600
| +65% | +$292K | 0.13% | 154 |
|
|
2018
Q4 | $297K | Buy |
+5,500
| New | +$297K | 0.09% | 215 |
|
|
2017
Q3 | – | Sell |
-6,800
| Closed | -$346K | – | 726 |
|
|
2017
Q2 | $346K | Buy |
+6,800
| New | +$346K | 0.05% | 348 |
|
|
2016
Q4 | – | Sell |
-5,900
| Closed | -$216K | – | 655 |
|
|
2016
Q3 | $216K | Buy |
+5,900
| New | +$216K | 0.06% | 514 |
|
|
2015
Q4 | – | Sell |
-9,700
| Closed | -$392K | – | 685 |
|
|
2015
Q3 | $392K | Buy |
+9,700
| New | +$392K | 0.11% | 316 |
|
|
2015
Q2 | – | Sell |
-11,600
| Closed | -$739K | – | 769 |
|
|
2015
Q1 | $739K | Buy |
+11,600
| New | +$739K | 0.15% | 174 |
|